Business commentator Rebecca Stevenson

Rebecca discusses how the surge in popularity of Ozempic, a drug heralded for its weight loss properties, has made Novo Nordisk one of Europe's most valuable companies. In 2022, US sales of Ozempic contributed to 65% of the firm's global sales. And a roundup of the Icehouse showcase, where New Zealand entrepreneurs pitched their startups to around 900 well-healed potential investors. Rebecca Stevenson is a senior writer at interest.co.nz